Posted by Michael Wonder on 06 Dec 2025
New resource: understanding Canada’s drug approval and reimbursement pathway
3 December 2025 - Understanding how new oncology and non-oncology drugs move through Canada’s regulatory and drug access pathways can be complex.
Canada’s Drug Agency (CDA-AMC) has developed a new educational resource that sheds light on and helps increase understanding of the drug system in Canada.
The newly published online explainer details the steps new drugs take along this pathway, from research and regulatory review through to price negotiation, listing, and reimbursement.
